Skip to main content
Premium Trial:

Request an Annual Quote

High-Throughput Genomics Awarded NCI Grant for Toxicity Testing, Array Development

NEW YORK, March 16 (GenomeWeb News) - High-Throughput Genomics has been awarded a two-year, $500,000 grant from the National Cancer Institute to identify and validate sets of genes for toxicity studies and develop a new array product, the company said today.

HTG said it plans to make "two-pronged" use of the funds, awarded by NCI's Division of Cancer Treatment & Diagnosis.

The company first plans to identify and validate a set of genes that can be used to predict the toxicity of compounds before testing in animals or humans. HTG said it will also use the funds to develop and validate a new medium-density array -- measuring 75 to 300 genes per well - to measure DNA, RNA, or protein molecules.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.